Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.3
1.94
NAV
₹29.62
₹403.64
Fund Started
20 Jun 2019
04 Jun 1999
Fund Size
₹837.41 Cr
₹3989.42 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-1.53%
-3.88%
3 Year
20.24%
22.21%
5 Year
12.57%
14.98%
Equity
98.81%
96.59%
Cash
1.19%
3.34%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.47% |
Apollo Hospitals Enterprise Ltd. | 7.14% |
Cipla Ltd. | 6.08% |
Torrent Pharmaceuticals Ltd. | 4.71% |
JB Chemicals & Pharmaceuticals Ltd. | 4.51% |
Abbott India Ltd. | 4.48% |
Ajanta Pharma Ltd. | 4.28% |
Aurobindo Pharma Ltd. | 4.11% |
Fortis Healthcare Ltd. | 3.99% |
Lupin Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Jun 2019
04 Jun 1999